VENLAFAXINE HYDROCHLORIDE
- Product NDC
- 55648-717
- 11-digit product format
- 556480717
- Labeler code
- 55648
- Product ID
- 55648-717_cd51dc6a-6737-49ce-b330-bb8cd16d8542
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Wockhardt Limited
- Application
- ANDA078865
- Marketing category
- ANDA
- Marketing start
- 2011-04-14
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55648-717-01 | VENLAFAXINE HYDROCHLORIDE | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 3 |
| 55648-717-02 | VENLAFAXINE HYDROCHLORIDE | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | | 3 |
| 55648-717-03 | VENLAFAXINE HYDROCHLORIDE | 8 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 8 | | 3 |
| 55648-717-03 | VENLAFAXINE HYDROCHLORIDE | 16 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 16 | | 3 |
| 55648-717-04 | VENLAFAXINE HYDROCHLORIDE | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | | 3 |
| 55648-717-05 | VENLAFAXINE HYDROCHLORIDE | 500 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 500 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| ETHYLCELLULOSES | INACTIVE INGREDIENT | 7Z8S9VYZ4B | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| SODIUM BICARBONATE | INACTIVE INGREDIENT | 8MDF5V39QO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55648-717 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [WOCKHARDT LIMITED] | 3 | Legacy NDC, 6 package rows | 20140221_c32ccd4d-77b4-4451-8c03-ffc6484bc1f3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 55648-717-01 | 55648071701 | 30 in 1 BOTTLE | Historical |
| 55648-717-02 | 55648071702 | 1000 in 1 BOTTLE | Historical |
| 55648-717-03 | 55648071703 | 8 in 1 BLISTER PACK | Historical |
| 55648-717-04 | 55648071704 | 90 in 1 BOTTLE | Historical |
| 55648-717-05 | 55648071705 | 500 in 1 BOTTLE | Historical |